KR19980071337A - 옥사카르바제핀 필름 코팅 정제 - Google Patents

옥사카르바제핀 필름 코팅 정제 Download PDF

Info

Publication number
KR19980071337A
KR19980071337A KR1019980004327A KR19980004327A KR19980071337A KR 19980071337 A KR19980071337 A KR 19980071337A KR 1019980004327 A KR1019980004327 A KR 1019980004327A KR 19980004327 A KR19980004327 A KR 19980004327A KR 19980071337 A KR19980071337 A KR 19980071337A
Authority
KR
South Korea
Prior art keywords
oxacarbazepine
particle size
approximately
average particle
granules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019980004327A
Other languages
English (en)
Korean (ko)
Inventor
부르크하르트 쉬뤼터만
Original Assignee
니콜레 케르커
노파르티스 아게
헨리테 브룬너
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4184588&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR19980071337(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 니콜레 케르커, 노파르티스 아게, 헨리테 브룬너 filed Critical 니콜레 케르커
Publication of KR19980071337A publication Critical patent/KR19980071337A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
KR1019980004327A 1997-02-14 1998-02-13 옥사카르바제핀 필름 코팅 정제 Ceased KR19980071337A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH331/97 1997-02-14
CH33197 1997-02-14

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020090024168A Division KR20090037873A (ko) 1997-02-14 2009-03-20 옥사카르바제핀 필름 코팅 정제

Publications (1)

Publication Number Publication Date
KR19980071337A true KR19980071337A (ko) 1998-10-26

Family

ID=4184588

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1019980004327A Ceased KR19980071337A (ko) 1997-02-14 1998-02-13 옥사카르바제핀 필름 코팅 정제
KR1020090024168A Ceased KR20090037873A (ko) 1997-02-14 2009-03-20 옥사카르바제핀 필름 코팅 정제
KR1020120065092A Ceased KR20120079826A (ko) 1997-02-14 2012-06-18 옥사카르바제핀 필름 코팅 정제

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020090024168A Ceased KR20090037873A (ko) 1997-02-14 2009-03-20 옥사카르바제핀 필름 코팅 정제
KR1020120065092A Ceased KR20120079826A (ko) 1997-02-14 2012-06-18 옥사카르바제핀 필름 코팅 정제

Country Status (31)

Country Link
US (2) US20070036863A1 (enExample)
EP (1) EP0966287B1 (enExample)
JP (3) JP2000511935A (enExample)
KR (3) KR19980071337A (enExample)
CN (2) CN1626093A (enExample)
AR (1) AR011142A1 (enExample)
AT (1) ATE239481T1 (enExample)
AU (1) AU738030B2 (enExample)
BR (1) BR9807368A (enExample)
CA (1) CA2277791C (enExample)
CO (1) CO4920215A1 (enExample)
CY (1) CY2480B1 (enExample)
CZ (1) CZ298840B6 (enExample)
DE (1) DE69814367T2 (enExample)
DK (1) DK0966287T3 (enExample)
ES (1) ES2199422T3 (enExample)
HU (1) HU227807B1 (enExample)
ID (1) ID22348A (enExample)
MY (1) MY117582A (enExample)
NO (1) NO327486B1 (enExample)
NZ (1) NZ336946A (enExample)
PE (1) PE58999A1 (enExample)
PL (1) PL193332B1 (enExample)
PT (1) PT966287E (enExample)
RU (1) RU2201218C2 (enExample)
SK (1) SK284503B6 (enExample)
TR (1) TR199901804T2 (enExample)
TW (1) TW529957B (enExample)
UY (1) UY24888A1 (enExample)
WO (1) WO1998035681A1 (enExample)
ZA (1) ZA981205B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
GB9925962D0 (en) * 1999-11-02 1999-12-29 Novartis Ag Organic compounds
US6368628B1 (en) * 2000-05-26 2002-04-09 Pharma Pass Llc Sustained release pharmaceutical composition free of food effect
WO2003053416A1 (en) 2001-12-21 2003-07-03 Pfizer Products Inc. Directly compressible formulations of azithromycin
GB0221956D0 (en) * 2002-09-20 2002-10-30 Novartis Ag Organic compounds
MXPA06002392A (es) 2003-09-03 2006-06-20 Novartis Ag Uso de oxcarbazepina para el tratamiento de dolor neuropatico diabetico y la mejora del sueno.
PE20051156A1 (es) * 2004-03-22 2006-02-13 Novartis Ag Formulaciones de matriz orales que comprenden licarbazepina
AR048672A1 (es) * 2004-03-22 2006-05-17 Novartis Ag Tabletas de desintegracion que comprenden licarbazepina
US8367105B2 (en) 2004-11-10 2013-02-05 Teva Pharmaceutical Industries, Ltd. Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
WO2007039420A1 (en) * 2005-09-23 2007-04-12 F. Hoffmann-La Roche Ag Novel dosage formulation
DK2774925T3 (en) 2005-11-08 2017-02-27 Vertex Pharma Heterocyclic modulators of ATP binding cassette transporters
CA2628716C (en) 2005-11-10 2016-09-27 Alphapharm Pty Ltd Process to control particle size
AU2006313009B2 (en) * 2005-11-10 2013-10-24 Alphapharm Pty Ltd Process to control particle size
CN101336105A (zh) * 2006-01-31 2008-12-31 特瓦制药工业有限公司 奥卡西平药物制剂及其制备方法，其中奥卡西平具有宽且多峰的粒度分布
EP2029118A2 (en) * 2006-01-31 2009-03-04 Teva Pharmaceutical Industries, Inc. Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution
AU2007242062A1 (en) * 2006-04-21 2007-11-01 Alphapharm Pty Ltd Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns
EP2018157A2 (en) 2006-04-26 2009-01-28 Astron Research Limited Controlled release formulation comprising anti-epileptic drugs
CN101489560B (zh) * 2006-04-26 2015-11-25 苏佩努斯制药公司 具有s形释放曲线的奥卡西平控释制剂
US20080138403A1 (en) * 2006-12-08 2008-06-12 Sun Pharmaceutical Industries Ltd. Pharmaceutical dosage forms of oxcarbazepine
JP2010513324A (ja) 2006-12-21 2010-04-30 アルファファーム ピーティーワイ リミテッド 医薬化合物および医薬組成物
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
EP1970056A1 (en) * 2007-03-15 2008-09-17 Polichem S.A. Time-specific delayed/pulsatile release dosage forms
WO2008141751A2 (en) * 2007-05-23 2008-11-27 Ratiopharm Gmbh Pharmaceutical compositions comprising oxcarbazepine
US8372431B2 (en) 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
CN103626744B (zh) 2007-12-07 2016-05-11 沃泰克斯药物股份有限公司 3-(6-(1-(2,2-二氟苯并[d][1,3]间二氧杂环戊烯-5-基)环丙烷甲酰氨基)-3-甲基吡啶-2-基)苯甲酸的固体形式
EP2555755B2 (en) 2010-04-07 2019-07-10 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereof
HRP20210516T2 (hr) 2013-11-12 2021-10-01 Vertex Pharmaceuticals Incorporated Postupak proizvodnje farmaceutskih pripravaka za liječenje bolesti koje su posredovane putem cftr
CN103735527B (zh) * 2013-12-24 2014-09-10 武汉人福药业有限责任公司 一种奥卡西平片剂及其制备方法
WO2018208242A1 (en) 2017-05-10 2018-11-15 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Formulation of deferasirox tablet for oral suspension composition with better processability
TW202444706A (zh) 2019-05-16 2024-11-16 瑞士商諾華公司 N-[4-(氯二氟甲氧基)苯基]-6-[(3r)-3-羥基吡咯啶-1-基]-5-(1h-吡唑-5-基)吡啶-3-甲醯胺之結晶形狀

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75561C (fi) * 1979-10-30 1988-07-11 Ciba Geigy Ag Foerfarande foer framstaellning av 5- karbamoyl-10-oxo-10,11-dihydro-5h-dibens/b,f/azepin och daertill noedvaendiga mellanprodukter.
CH649080A5 (de) * 1981-04-16 1985-04-30 Ciba Geigy Ag 5h-dibenz(b,f)azepin-5-carboxamide als mittel zur prophylaxe und behandlung von zerebraler leistungsinsuffizienz.
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
JPS6257467A (ja) * 1985-09-06 1987-03-13 Asahi Glass Co Ltd コ−テイング剤組成物
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
CH668187A5 (de) * 1986-08-07 1988-12-15 Ciba Geigy Ag Therapeutisches system mit systemischer wirkung.
DD295760A5 (de) * 1989-01-31 1991-11-14 Martin-Luther-Universitaet Halle Wittenberg,De Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5231089A (en) * 1991-12-02 1993-07-27 University Of Florida Method of improving oral bioavailability of carbamazepine
FR2699077B1 (fr) * 1992-12-16 1995-01-13 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes.
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
US5478654A (en) * 1994-05-06 1995-12-26 Gencorp Inc. Solventless carboxylated butadiene-vinylidene chloride adhesives for bonding rubber to metal
US5980942A (en) * 1997-01-23 1999-11-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release matrix tablet formulations of carbamazepine
US6296873B1 (en) * 1997-01-23 2001-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release delivery system for carbamazephine derivatives
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones

Also Published As

Publication number Publication date
ATE239481T1 (de) 2003-05-15
PE58999A1 (es) 1999-06-25
UY24888A1 (es) 2000-12-29
US20080014269A1 (en) 2008-01-17
HUP0000886A2 (hu) 2000-09-28
CZ298840B6 (cs) 2008-02-20
SK109899A3 (en) 2000-03-13
ES2199422T3 (es) 2004-02-16
DE69814367T2 (de) 2004-02-26
AR011142A1 (es) 2000-08-02
JP2000511935A (ja) 2000-09-12
CN1247471A (zh) 2000-03-15
CA2277791C (en) 2008-11-18
CN1170542C (zh) 2004-10-13
DE69814367D1 (de) 2003-06-12
HK1024423A1 (en) 2000-10-13
PT966287E (pt) 2003-09-30
WO1998035681A1 (en) 1998-08-20
EP0966287B1 (en) 2003-05-07
KR20120079826A (ko) 2012-07-13
JP2010132694A (ja) 2010-06-17
TW529957B (en) 2003-05-01
JP2006077029A (ja) 2006-03-23
CO4920215A1 (es) 2000-05-29
CZ287999A3 (cs) 1999-11-17
BR9807368A (pt) 2000-03-14
SK284503B6 (sk) 2005-05-05
NZ336946A (en) 2001-02-23
MY117582A (en) 2004-07-31
AU738030B2 (en) 2001-09-06
NO993919D0 (no) 1999-08-13
DK0966287T3 (da) 2003-08-25
PL193332B1 (pl) 2007-02-28
US20070036863A1 (en) 2007-02-15
KR20090037873A (ko) 2009-04-16
CA2277791A1 (en) 1998-08-20
HUP0000886A3 (en) 2002-10-28
CN1626093A (zh) 2005-06-15
NO993919L (no) 1999-08-13
PL334959A1 (en) 2000-03-27
RU2201218C2 (ru) 2003-03-27
ZA981205B (en) 1998-08-14
ID22348A (id) 1999-09-30
HU227807B1 (en) 2012-03-28
CY2480B1 (en) 2005-06-03
NO327486B1 (no) 2009-07-13
TR199901804T2 (xx) 1999-09-21
EP0966287A1 (en) 1999-12-29
AU6622298A (en) 1998-09-08

Similar Documents

Publication Publication Date Title
KR20090037873A (ko) 옥사카르바제핀 필름 코팅 정제
AU777705B2 (en) Pharmaceutical compositions
US5472714A (en) Double-layered oxcarbazepine tablets
US7037525B2 (en) Oxacarbazepine film-coated tablets
WO2009026621A1 (en) Pharmaceutical compound & composition
HK1024423B (en) Oxacarbazepine film-coated tablets
NZ509391A (en) Oxacarbazepine film-coated tablets further comprising a hydrophobic permeable outer coating containing iron oxide from 0.3 to 0.9 mg per tablet
MXPA99007514A (en) Oxacarbazepine film-coated tablets

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19980213

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20000203

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19980213

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20020430

Patent event code: PE09021S01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20021224

Patent event code: PE09021S01D

A107 Divisional application of patent
PA0107 Divisional application

Comment text: Divisional Application of Patent

Patent event date: 20030224

Patent event code: PA01071R01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20040630

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20090119

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20040630

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

Patent event date: 20021224

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

Patent event date: 20020430

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20090218

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20090119

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20101101

Appeal identifier: 2009101001408

Request date: 20090218

A107 Divisional application of patent
PA0107 Divisional application

Comment text: Divisional Application of Patent

Patent event date: 20090320

Patent event code: PA01071R01D

J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20090218

Effective date: 20101101

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20101102

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20090218

Decision date: 20101101

Appeal identifier: 2009101001408

J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

PJ2001 Appeal

Patent event date: 20101102

Comment text: Trial Decision on Objection to Decision on Refusal

Patent event code: PJ20011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20110922

Appeal identifier: 2010201009095

Request date: 20101208

J302 Written judgement (patent court)

Free format text: JUDGMENT (PATENT COURT) FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20101208

Effective date: 20110922

PJ1302 Judgment (patent court)

Patent event date: 20110926

Comment text: Written Judgment (Patent Court)

Patent event code: PJ13021S01D

Request date: 20101208

Decision date: 20110922

Appeal identifier: 2010201009095

Appeal kind category: Appeal against decision to decline refusal

J121 Written withdrawal of request for trial
PC1202 Submission of document of withdrawal before decision of registration

Comment text: [Withdrawal of Procedure relating to Patent, etc.] Withdrawal (Abandonment)

Patent event code: PC12021R01D

Patent event date: 20111007

PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20111007

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2009101001408

Request date: 20090218

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20101101

WITB Written withdrawal of application